Can the Sigma-1 Receptor Agonist Fluvoxamine Prevent Schizophrenia?

E-ISSN： 1996-3181|8|6|470-474

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.8, Iss.6, 2009-01, pp. : 470-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sigma-1 Receptor Chaperones and Diseases

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 3, 2009-09 ,pp. : 184-189

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands

Current Neuropharmacology, Vol. 6, Iss. 4, 2008-12 ,pp. : 344-366

Bentham Science Publishers

Access to resources Recommend Favorite

Can Angiotensin Receptor Antagonists Prevent Restenosis After Stent Placement?

By Peters S.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 143-148

Adis International

Access to resources Recommend Favorite

Chronic lithium chloride fails to prevent imipramine-induced sensitization to the dopamine D 2 -like receptor agonist quinpirole

By D'Aquila P.S. Collu M. Devoto P. Serra G.

European Journal of Pharmacology, Vol. 395, Iss. 2, 2000-04 ,pp. : 157-160

Elsevier

Access to resources Recommend Favorite

Histamine H₁ receptor occupancy by the new-generation antidepressants fluvoxamine and mirtazapine: a positron emission tomography study in healthy volunteers

By Sato Hirotoshi Ito Chihiro Tashiro Manabu Hiraoka Kotaro Shibuya Katsuhiko Funaki Yoshihito Iwata Ren Matsuoka Hiroo Yanai Kazuhiko

Psychopharmacology, Vol. 230, Iss. 2, 2013-11 ,pp. : 227-234

Springer Publishing Company

Access to resources Recommend Favorite